Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of …

R Freeman, E Durso-DeCruz, B Emir - Diabetes care, 2008 - Am Diabetes Assoc
OBJECTIVE—To evaluate the efficacy, safety, and tolerability of pregabalin across the
effective dosing range, to determine differences in the efficacy of three times daily (TID) …

[PDF][PDF] Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy

F ROY, E DURSO-DECRUZ, B EMIR - Diabetes Care, 2008 - scienceopen.com
OBJECTIVE—To evaluate the efficacy, safety, and tolerability of pregabalin across the
effective dosing range, to determine differences in the efficacy of three times daily (TID) …

[PDF][PDF] Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy

F ROY, E DURSO-DECRUZ, B EMIR - Diabetes Care, 2008 - Citeseer
OBJECTIVE—To evaluate the efficacy, safety, and tolerability of pregabalin across the
effective dosing range, to determine differences in the efficacy of three times daily (TID) …

Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy

RL Freeman, E Durso-DeCruz, B Emir - Diabetes Care, 2008 - dash.harvard.edu
OBJECTIVE—To evaluate the efficacy, safety, and tolerability of pregabalin across the
effective dosing range, to determine differences in the efficacy of three times daily (TID) …

[PDF][PDF] Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy

F ROY, E DURSO-DECRUZ, B EMIR - Diabetes Care, 2008 - core.ac.uk
OBJECTIVE—To evaluate the efficacy, safety, and tolerability of pregabalin across the
effective dosing range, to determine differences in the efficacy of three times daily (TID) …

Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy.

R Freeman, E Durso-Decruz, B Emir - Diabetes Care, 2008 - search.ebscohost.com
OBJECTIVE--To evaluate the efficacy, safety, and tolerability of pregabalin across the
effective dosing range, to determine differences in the efficacy of three times daily (TID) …

Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy: Findings from seven randomized, controlled trials across a range …

R Freeman, E Durso-DeCruz, B Emir - Diabetes Care, 2008 - search.proquest.com
To evaluate the efficacy, safety, and tolerability of pregabalin across the effective dosing
range, to determine differences in the efficacy of three times daily (TID) versus twice daily …

[HTML][HTML] Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral Neuropathy: Findings from seven randomized, controlled trials across …

R Freeman, E Durso-DeCruz, B Emir - Diabetes Care, 2008 - ncbi.nlm.nih.gov
OBJECTIVE—To evaluate the efficacy, safety, and tolerability of pregabalin across the
effective dosing range, to determine differences in the efficacy of three times daily (TID) …

Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of …

R Freeman, E Durso-DeCruz, B Emir - Diabetes Care, 2008 - go.gale.com
OBJECTIVE--To evaluate the efficacy, safety, and tolerability of pregabalin across the
effective dosing range, to determine differences in the efficacy of three times daily (TID) …

Efficacy, safety, and tolerability of pregabalin treatment for painful diabetic peripheral neuropathy: findings from seven randomized, controlled trials across a range of …

R Freeman, E Durso-Decruz, B Emir - Diabetes care, 2008 - pubmed.ncbi.nlm.nih.gov
Objective To evaluate the efficacy, safety, and tolerability of pregabalin across the effective
dosing range, to determine differences in the efficacy of three times daily (TID) versus twice …